Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115760) titled 'A Randomized Controlled Trial on the Efficacy of Tympanic Membrane Injection of PTMSC Exosomes in the Treatment of Sudden Deafness' on Dec. 31, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Zhujiang Hospital of Southern Medical University
Condition:
Sensorineural hearing loss
Intervention:
Experimental group:Combined use of PTMSC exosome tympanic cavity injection with dexamethasone injection solution
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target Sample Size: Experimental group:44;Control group:44;
Countries of Recruitment...